NCT00806858

Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus

NovoPen®4 Clinical Experience Programme: A Multicentre, Observational Study of NovoPen®4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 526 (actual)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This study is conducted in Asia. The aim of this observational study is to evaluate subjects' treatment satisfaction and to evaluate subjects' preference of pen device and the incidence of clinical technical complains while using NovoPen® 4 under normal clinical practice conditions.

Conditions

• Diabetes
• Diabetes Mellitus, Type 1
• Diabetes Mellitus, Type 2
• Delivery Systems

Interventions

Type	Name	Description
DEVICE	NovoPen® 4	Insulin administration by means of a NovoPen® 4 pen device

Timeline

• Start date: 2008-11-01
• Primary completion: 2009-07-01
• Completion: 2009-07-01
• First posted: 2008-12-11
• Last updated: 2016-11-23

Locations

1 site across 1 country: China